Novasep, a supplier of services and technologies for the life sciences industry, launched oXYgene for construction and operation of customer dedicated facilities for viral vectors production. Novasep recently announced the successful start-up of Senrise-IV, its flagship for bioproduction of viral vectors at large scale. Novasep now offers to capitalize on its unique engineering and CDMO expertises to shorten the time-to-market of its customers late-stage viral vector drug candidates. Novasep&...